Stockscreener 앱 받기
5.16
5.67%
-0.31
전일 마감가:
$5.47
열려 있는:
$5.37
하루 거래량:
301.98K
Relative Volume:
1.27
시가총액:
$187.28M
수익:
$16.10M
순이익/손실:
$-42.57M
주가수익비율:
-3.6588
EPS:
-1.4103
순현금흐름:
$-38.53M
1주 성능:
-7.03%
1개월 성능:
-26.07%
6개월 성능:
+18.89%
1년 성능:
-25.11%
1일 변동 폭
$5.13
$5.37
1주일 범위
$5.13
$6.06
52주 변동 폭
$3.76
$8.95
프로파운드 메디컬 Stock (PROF) Company Profile
명칭
Profound Medical Corp
전화
647-476-1350
주소
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.16 | 187.28M | 16.10M | -42.57M | -38.53M | -1.4103 |
|
ABT
Abbott Laboratories
|
107.19 | 186.26B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 130.02B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.53B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.89B | 6.07B | 1.06B | 1.34B | 1.8063 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | Lake Street | Buy |
| 2024-07-16 | 업그레이드 | Stifel | Hold → Buy |
| 2023-11-28 | 개시 | Stifel | Hold |
| 2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-15 | 개시 | Jefferies | Buy |
모두보기
프로파운드 메디컬 주식(PROF)의 최신 뉴스
Returns Recap: Can Profound Medical Corp sustain its profitability2026 Macro Moves & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Profound Medical stock rating reiterated by Raymond James on trial data - Investing.com Australia
Profound Medical reports CAPTAIN trial meets primary safety endpoint - Yahoo Finance
Profound Medical's (PROF) TULSA Procedure Shows Superior Safety Outcomes - GuruFocus
Profound Medical Corp. Reports Results of CAPTAIN Trial Comparing MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy - marketscreener.com
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence - Bitget
Profound Medical Trial Shows TULSA Improves Prostate Cancer Outcomes - TipRanks
Profound Medical (PROF) trial: TULSA tops robotic surgery on key safety outcomes - Stock Titan
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence - Yahoo Finance
Aug Outlook: What hedge funds are buying Profound Medical Corp2026 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
(PRN) Comprehensive Trading Strategy Report (PRN:CA) - Stock Traders Daily
Profound Medical Announces Board Resignation and New Appointment - TipRanks
Medical Co.'s TULSA-PRO Installed Base Growth & CAPTAIN Trial Data Could Accelerate Adoption in 2026 - streetwisereports.com
Profound Medical to Present First CAPTAIN Trial Results and Steps Up Investor Outreach - The Globe and Mail
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 - Investing News Network
Profound Medical to Host Investor Call March 13 on First CAPTAIN Trial Outcomes Presented at EAU 2026 - TradingView
Profound Medical (PROF) Awaits Key Clinical Data Presentation - GuruFocus
(PRN) Technical Pivots with Risk Controls (PRN:CA) - Stock Traders Daily
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript - Insider Monkey
Profound Medical (TSX:PRN) Narrowing EPS Loss In Q3 2025 Tests Growth Optimism Narrative - simplywall.st
History Review: Can Profound Medical Corp beat the S P 500Market Volume Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Street Watch: Is OVBC forming a bullish divergenceEarnings Performance Report & Verified Swing Trading Watchlist - baoquankhu1.vn
Profound Medical (TSE:PRN) Trading Down 26%Time to Sell? - MarketBeat
Profound Medical reports net loss of USD 8.2M in Q4 2025 - Medical Buyer
Profound Medical (NASDAQ:PROF) Issues Earnings Results - MarketBeat
Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: R - GuruFocus
Profound Medical Posts Record Q4 Revenue as TULSA-PRO Adoption and Global Expansion Accelerate - The Globe and Mail
Profound Medical Q4 Earnings Call Highlights - Yahoo Finance
Aug Sentiment: Can Profound Medical Corp beat the S P 500July 2025 Weekly Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Investing News Network
Earnings call transcript: Profound Medical Q4 2025 EPS surprises, stock rises - Investing.com South Africa
Profound Medical (PROF) Reports Q4 Revenue Below Expectations - GuruFocus
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Profound 10-K: Revenue $16.1M, EPS loss $1.41 - TradingView
Profound Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Profound Medical Q4 Earnings Assessment - Benzinga
Profound Medical Corp. Q4 Profit Climbs - Nasdaq
Profound Medical Brief: Reports Q4 Revenue of US$6.0 Mln, Up From US$4.2 Mln a Year Earlier - marketscreener.com
Profound Medical Brief: Reports a Fourth-Quarter Loss of US$8.2 Mln, or US$0.27 per Share, Compared To a Loss of US$4.9 Mln, or US$0.20 in the Year-Prior Quarter - marketscreener.com
Profound Medical $PROF Shares Purchased by First Eagle Investment Management LLC - MarketBeat
Profound Medical's Earnings: A Preview - Benzinga
Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: Wh - GuruFocus
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline - Finviz
Profound Medical (PROF) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Risk Hedge: What is the Moat Score of NYXHEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Tech Rally: What hedge funds are buying Profound Medical CorpPortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Energy Moves: Can Affimed NV outperform under higher oil pricesInsider Selling & Weekly Consistent Profit Watchlists - baoquankhu1.vn
(PRN) Risk-Controlled Trading Report (PRN:CA) - Stock Traders Daily
Certain stock options of Profound Medical Corp. are subject to a Lock-Up Agreement Ending on 22-FEB-2026. - marketscreener.com
Is Profound Medical Corp. trading at a discountPortfolio Profit Report & Daily Stock Momentum Reports - mfd.ru
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):